click below
click below
Normal Size Small Size show me how
Shock
types of shock
Question | Answer |
---|---|
pathophysiology of shock | alterations in at least 1 of 4 components: blood volume, contractility, blood flow, vascular resistance |
cardiogenic shock | pump failure results in hemodynamic changes decreased cardiac output and decreased tissue perfusion |
precipitating factors of cardiogenic shock | MI, cardiomyopathy, blunt cardiac trauma, cardiac tamponade, pulmonary hypertension, dysrhythmias |
early manifestations of cardiogenic shock | tachycardia, hypotension, increased myocardial O2 consumption |
physical assessment of cardiogenic shock | tachypneic, cool, clammy skin, decreased capillary refill, crackles in lungs, confusion, agitation, decreased renal perfusion, decreased urine output |
management of cardiogenic shock | treat dysrhythmias, cardiac catheterization to restore flow, intraaortic balloon pump, VAD device |
medications- positive inotropes to help contract heart | dopamine, dobutamine, digoxin, milrenon |
medications to help decrease preload | diuretics, vasodilators, nitrates |
when to know if vasodilators are effective | if patient is pink and warm |
medications to help decrease afterload | ACE inhibitors, positive inotropes and vasodilators |
hypovolemic shock | inadequate circulating volume creates hemodynamic changes including decreased preload decreased stroke volume decreased cardiac output |
manifestations of hypovolemic shock | anxious, increased RR, increased HR, cardiac output decreased, decreased stroke volume, decreased urine output |
management of hypovolemic shock | determine and treat underlying cause, stop loss of fluid, replace fluids (monitor urine output) |
neurogenic shock | massive vasodilation without compensation due to loss of SNS vasoconstriction tone |
causes of neurogenic shock | SCI, trauma, depression of medulla - opiods / drugs |
clinical manifestations of neurogenic shock | decreased blood pressure, decreased HR, inability to regulate temperature, dry skin |
management of neurogenic shock | atropine (increases HR) fluids |
anaphylactic shock | acute, life-threatening hypersensitivity (allergic) reaction |
causes of anaphylactic shock | drugs, vaccines, food, insect venom |
clinical manifestations of anaphylactic shock | hypotension, respiratory distress, dizziness, chest pain, wheezing, swelling |
management of anaphylactic shock | prevention!!!!!! epinephrine IM benadryl, steroids, vasopressors, bronchodilators possible ET intubation |
septic shock | presence of sepsis with hypotension despite fluid resuscitation |
causes of septic shock | gram negative and positive bacteria |
clinical manifestations of septic shock | hypoxia, increased coagulation, inflammation, vasodilation, increased RR, decreased ejection fraction, decreased urine output |
management of septic shock | find the cause and start antibiotics but must get cultures first fluids and vasopressors |
obstructive shock | physical impairment to adequate circulatory blood flow |
possible causes of obstructive shock | cardiac tamponade, pulmonary embolism, tension pneumothorax |
clinical manifestations of obstructive shock | hypoxia, jugular vein distention, chest pain, pulmonary edema |
management of obstructive shock | mechanical decompression, chest tube, thrombolytics, radiation or removal of mass |
Shock: stage 1 | initiation: hypoperfusion- inadequate delivery or extraction of oxygen causes lactic acid buildup- no obvious clinical signs |
shock stage 2 | compensatory sustained reduction in tissue perfusion ANS releases norepinephrine and cortisol RAAS system initiated CM- decrease in BP, increased HR, RR, and decreased urine output |
shock stage 3 | progressive compensatory mechanisms fail- all organs compromised CMs: AKI, ARDS, change in mental status, decreased cardiac output, increased RR, crackles, MI, GI bleed |
shock stage 4 | refractory anaerobic metabolism due to decreased perfusion blood and fluid leave intravascular space hypotension and hypoxemia unresponsive to therapy |
CNS assessment | decreased LOC, blurred vision, confusion, restlessness and anxious |
pulmonary early stage assessment | increased ventilation, perfusion mismatch hyperventilation tachypnea |
pulmonary late stage assessment | pulmonary vasoconstriction increased capillary permeability alveolar edema moist crackles |
GI assessment | decreased intestinal activity decreased blood supply |
hepatic assessment | failure to metabolize drugs and waste (buildup of lactic acid and ammonia) increased susceptibility to toxicity |
integumentary assessment | pale and cool to mottled and blue |
diagnostic findings | CBC, coagulation studies, BMP, serum lactate acid level (5-20), EKG, CXR, hemodynamic monitoring |
cardiogenic shock diagnostics | cardiac enzymes, echo, cardiac catheter, CT scan |
hypovolemic shock diagnostics | type and crossmatch, fecal occult, EGD |
septic shock diagnostics | blood, urine, and wound cultures |
medical management of shock | treat cause, fluid resuscitation, nutrition (within first 24 hrs), optimize oxygen delivery and O2 demands |
crystalloids | 0.9 NS, or LR |
colloids | albumin when volume is lost due to loss of plasman vs loss of blood |
vasopressors are used when | after fluid resuscitation keep MAP > 65 vasopressin |
vasodilators are used to | break cycle of widespread vasoconstriction nitroglycerin |